Vitaeris is a privately-owned biopharmaceutical company headquartered in Vancouver, British Columbia, Canada. Founded in early 2016, we are focused on the development of clazakizumab, a humanized anti-interleukin 6 (IL-6) monoclonal antibody. Clazakizumab was originally discovered and developed in autoimmune conditions such as rheumatoid arthritis by Alder Biopharmaceuticals (Bothell, Washington). We exclusively licensed wo...
Vitaeris is a privately-owned biopharmaceutical company headquartered in Vancouver, British Columbia, Canada. Founded in early 2016, we are focused on the development of clazakizumab, a humanized anti-interleukin 6 (IL-6) monoclonal antibody. Clazakizumab was originally discovered and developed in autoimmune conditions such as rheumatoid arthritis by Alder Biopharmaceuticals (Bothell, Washington). We exclusively licensed worldwide rights to clazakizumab from Alder in May 2016 and since then have fully pivoted development of the antibody into the field of kidney transplant rejection.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.